(Q39902009)

English

Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

0 references

anti-retroviral agent

0 references

2

object named as

Rony Zachariah

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Anthony D Harries

9

object named as

Anthony Harries

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

object named as

Marcel Manzi

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

8

object named as

Line Arnould

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Katie Harries

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Peter Firmenich

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Richard Mathela

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Joseph Drabo

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

G Onadja

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

23 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

104

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

154-161

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Slower heterosexual spread of HIV-2 than HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

The global distribution of human immunodeficiency virus type 2 (HIV-2) infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Detection of circulating human immunodeficiency virus type 2 in plasma by reverse transcription polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Retrospective study of maternal HIV-1 and HIV-2 infections and child survival in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Antiretroviral therapy for HIV-2 infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Effect of methodology on detection of HIV-1/HIV-2 dual infections in Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

21 January 2018

Lessons from the second AIDS virus, HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

7 January 2021

HIV-2-infected patients survive longer than HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

7 January 2021

Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, west Africa: no protection of HIV-2 against HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

7 January 2021

Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

7 January 2021

[Efficacy and tolerance of antiretroviral therapy in HIV-2 infected patients in Dakar: preliminary study]

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

7 January 2021

Vertical transmission of HIV-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

7 January 2021

AIDS following mother-to-child transmission of HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.08.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRSTMH.2009.08.012

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39902009&oldid=2092385599"